Introduced by Sen. Dayna Polehanki D-Livonia on February 24, 2022
To earmark certain license fees imposed on prescription drug makers to a government “prescription drug affordability fund” Senate Bill 889 would authorize. Official Text and Analysis.
Referred to the Senate Health Policy and Human Services Committee on February 24, 2022